Article Information
History
- March 13, 2022.
Article Versions
- You are currently viewing Version 1 of this article (March 13, 2022 - 03:15).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Sandra Lopez-Leon, MD, PhD1,2,
- Talia Wegman-Ostrosky, MD, PhD3,
- Cipatli Ayuzo del Valle, MD4,
- Carol Perelman, BSc5,
- Rosalinda Sepulveda, MD PhD6,
- Paulina A Rebolledo, MD, MSc7,8,
- Angelica Cuapio, MD, Dr. Med9 and
- Sonia Villapol, PhD10,11,*
- 1Quantitative Safety & Epidemiology, Novartis Pharmaceuticals, New Jersey, USA
- 2Rutgers Center for Pharmacoepidemiology and Treatment Science, Rutgers University, New Jersey, USA
- 3Instituto Nacional de Cancerología, Subdirección de Investigación básica, Ciudad de México, México
- 4Departamento de Pediatría, Tecnologico de Monterrey, Mexico
- 5Universidad Nacional Autónoma de México (UNAM), SOMEDICyT, RedMPC, México
- 6Harvard T.H. Chan School of Public Health Boston, Massachusetts, USA
- 7Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, USA
- 8Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA
- 9Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institute, Stockholm, Sweden
- 10Department of Neurosurgery, Center for Neuroregeneration, Houston Methodist Research Institute, Houston, Texas, USA
- 11Department of Neuroscience in Neurological Surgery, Weill Cornell Medical College, New York, USA
- ↵*Corresponding author; email: svillapol{at}houstonmethodist.org
Posted March 13, 2022.
